Synergy CHC (SNYR) investor relations material

Company overview and business model

• Operates in consumer health care, beauty, and lifestyle products, with two main brands: FOCUSfactor (brain health supplement) and Flat Tummy (wellness and nutrition for women).

• Products are distributed through major retailers (Costco, Amazon, Walmart, CVS, etc.) and direct-to-consumer channels, with international expansion into Canada and the UK.

• Growth strategy includes expanding product SKUs, international markets, and leveraging digital engagement (apps, social media).

• Asset-light model using contract manufacturing for scalability and flexibility.

Financial performance and metrics

• Net revenue for 2024 was $34.8 million, down 19% from $42.8 million in 2023.

• For the nine months ended September 30, 2025, net revenue was $24.3 million, a 1% decrease year-over-year.

• FOCUSfactor accounted for 86% of net revenue in the first nine months of 2025; Flat Tummy was 14%.

• Revenue from a license agreement in foreign markets was $2.9 million in the first nine months of 2025.

Use of proceeds and capital allocation

• Proceeds will be used for research and development, working capital, general corporate purposes, potential acquisitions, and debt reduction.

• Management retains broad discretion over allocation of net proceeds.